300
Views
4
CrossRef citations to date
0
Altmetric
Review

Global patent landscape of programmed cell death 1: implications of the rapid expansion

, , , , &
Pages 69-80 | Received 26 Jun 2017, Accepted 06 Sep 2017, Published online: 19 Sep 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Jorge Cebada, Martin Perez-Santos, Cindy Bandala, Eleazar Lara-Padilla, Irma Herrera-Camacho, Nora Hilda Rosas-Murrieta, Lourdes Millán-Pérez Peña, Eduardo Monjaraz, Amira Flores & Maricruz Anaya-Ruiz. (2021) OX40 agonists for cancer treatment: a patent review. Expert Opinion on Therapeutic Patents 31:1, pages 81-90.
Read now
Martin Perez-Santos, Maricruz Anaya-Ruiz, Jorge Cebada, Cindy Bandala, Gerardo Landeta, Patricia Martínez-Morales & Nemesio Villa-Ruano. (2019) LAG-3 antagonists by cancer treatment: a patent review. Expert Opinion on Therapeutic Patents 29:8, pages 643-651.
Read now
Jingwen Qu, Jiahong Lu & Yuanjia Hu. (2019) Research and development of anti-Parkinson’s drugs: an analysis from the perspective of technology flows measured by patent citations. Expert Opinion on Therapeutic Patents 29:2, pages 127-135.
Read now

Articles from other publishers (1)

Xiangjun Kong, Huali Zuo, Hsien-Da Huang, Qianru Zhang, Jiayu Chen, Chengwei He & Yuanjia Hu. (2023) STING as an emerging therapeutic target for drug discovery: Perspectives from the global patent landscape. Journal of Advanced Research 44, pages 119-133.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.